Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

The Case For Restricting Use Of Entresto

Executive Summary

Debate at American College of Cardiology annual meeting highlights areas where clinical questions remain about Novartis’ heart failure drug Entresto, despite a strong showing in the pivotal PARADIGM-HF study.



Related Companies